The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

Lundbeck has ended its bidding war with Alkermes to acquire Avadel Pharmaceuticals, saying that it will not increase its offer for the sleep disorder drug developer beyond the approximately $2.4 ...

Researchers say in future it may be possible to grow personalized organoids from patient’s own tissue, to test potential treatments in advance.

IBP-9414 will be the first live biotherapeutic product globally, according to officials at Infant Bacterial Therapeutics in Stockholm.

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical ...

Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.

The Fugaku supercomputer builds a highly detailed virtual mouse cortex with millions of neurons enabling unprecedented simulations.

Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for treating cervical cancer.

This academic-industry partnership reflects the need for a multidisciplinary approach to innovation in cell and gene therapy manufacturing.

Study shows social isolation following immune challenge is self-imposed and driven by an active neural process, rather than a secondary consequence of physiological symptoms of sickness.

EVE is a deep generative model combining evolutionary and human population data to estimate variant deleteriousness on a proteome-wide scale.